Free
⭐️4.2 / 5
Rating
🙌5
Ratings
📼4 scs
Content
📦w/o updates
Updates frequency
🗣❌ unsupported
Your locale
- Versions
- Price History
- Description
- FAQ
All Versions of MAPPP
1.2.71
June 22, 2023
-minor fixes
1.2.6
June 7, 2023
-Updates to text content.
1.2.5
January 4, 2023
Reference to application feature in Perioperative Management of the Antithrombotic Therapy, CHEST Guideline. Volume 162, Issue 5, E207-E243, November 1, 2022
Verbiage updates.
More1.2.4
December 28, 2022
Reference to application feature in Perioperative Management of the Antithrombotic Therapy, CHEST Guideline. Volume 162, Issue 5, E207-E243, November 1, 2022
Verbiage updates.
More1.2.3
December 27, 2022
Reference to application feature in Perioperative Management of the Antithrombotic Therapy, CHEST Guideline. Volume 162, Issue 5, E207-E243, November 1, 2022
Verbiage updates.
More1.2.2
July 21, 2021
Updated App Icons
Updated to include asking permission for app tracking
Various tweaks and minor updates
More1.2.1
October 1, 2020
Performance updates and improvements.
1.1.6
January 3, 2020
Fixed superscript typos to be subscript
1.1.5
December 10, 2019
Clinical updates to text and wording
1.1.4
December 8, 2017
- Miscellaneous formatting updates to HTML
- Minor content updates/fixes
- Added a new footnote for Warfarin
MorePrice History of MAPPP
Description of MAPPP
Despite the considerable efficacy of antithrombotics and the increased number of oral anticoagulants now available, preventable bleeding and thrombotic events are still unacceptably common. While recently marketed agents require less laboratory monitoring, problems with the clinical management of anticoagulated patients persist, particularly in the peri-procedural period.
Surgery and invasive medical interventions increase the risk of bleeding, while withholding anticoagulants increases the risk of thrombosis due to the underlying condition(s) for which anticoagulation was originally prescribed. The clinical team must therefore balance these competing risks and make educated decisions regarding the decision to interrupt oral anticoagulation for a medical procedure and, if interrupted, whether to "bridge" anticoagulation with injectable anticoagulants, such as low molecular weight heparin (LMWH) in warfarin treated patients.
This guide is intended to:
-Assist clinicians in the simultaneous evaluation of procedure-related bleeding risk and underlying risk of thrombosis
-Guide decisions regarding the interruption of anticoagulation and the use of anticoagulant "bridging"
-Provide detailed guidance for drug dosing and laboratory monitoring in the peri-procedural period
-Encourage clear communication between clinicians involved in prescribing anticoagulants and performing invasive procedures
This material was created by the multidisciplinary members of the Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, the Medicare Quality Improvement Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 10SOW-NY-AIM-7.3-14-01
Show less
MAPPP: FAQ
Yes, MAPPP works on iPad devices.
Island Peer Review Organization, Inc released the MAPPP app.
The minimum required iOS version for the app to work is 11.0 or higher.
The average rating for the MAPPP app is 4.2.
The Primary Genre Of The Mappp App Is Medical.
1.2.71 is the newly released MAPPP version.
The latest MAPPP update was rolled out on July 1, 2024.
The MAPPP app launched on February 5, 2023.
The content advisory rating for MAPPP is 12+.
You can use the MAPPP app in English.
No, MAPPP is not available on Apple Arcade.
No, MAPPP does not offer in-app purchases.
No, MAPPP does not support compatibility with Apple Vision Pro.